Skip to content

Alto Neuroscience ANRO Payments on Issuance Cost from Registration Statement

Payments on Issuance Cost from Registration Statement at other companies

PVL
Palvella TherapeuticsPVLA
$38.5K
TRV
Trevi Therapeutics, Inc.TRVI
$0
KDK
Kodiak AI, Inc. Common StockKDK
$0-100%
SoundHound AI, Inc. logo
SoundHound AI, Inc.SOUN
$0-100%
MH
McGraw Hill, Inc.MH
$0
Mineralys Therapeutics, Inc. logo
Mineralys Therapeutics, Inc.MLYS
$1K-90.0%

Other financials

Income statement

See full
Operating income-$27.1M-73.1%
Net income-$26.2M-73.0%
EPS (diluted)-$0.80-42.9%

Balance sheet

See full
Cash & equivalents$264.3M+63.9%
Total debt$20.9M-17.2%
Total equity$243.4M+75.0%
Total assets$276.3M+60.7%

Cash flow

See full
Operating cash flow-$27.1M-63.6%
CapEx$556.0K+2,217%
Free cash flow-$27.6M-66.7%

Valuation

See full
Market cap$887.88M+1,358%
Enterprise value$644.49M-958%

Returns & leverage

See full
Return on equity-38.9%+0.9pp
Debt / equity0.1×-0.1×
Current ratio20.5×-2.0×

Where this comes from

Reported directly by Alto Neuroscience in its filing.

Tagged under the XBRL concept alto:PaymentsOnIssuanceCostFromRegistrationStatement.

The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alto Neuroscience's payments on issuance cost from registration statement.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alto Neuroscience's payments on issuance cost from registration statement?
Alto Neuroscience (ANRO) reported payments on issuance cost from registration statement of $0 in Q1 2026.
How has Alto Neuroscience's payments on issuance cost from registration statement changed year-over-year?
Alto Neuroscience's payments on issuance cost from registration statement decreased by 100.0% year-over-year, from $419K to $0.
What does payments on issuance cost from registration statement mean?
Reflects cash outflows specifically related to the preparation and filing of registration statements for securities offerings. These costs are necessary to maintain compliance and facilitate the sale of equity or debt instruments. Monitoring these payments helps evaluate the administrative burden and cost-to-capital ratio of public financing activities.